There is a medical name for it. That pang of stress and worry that grabs you every time you look in the mirror and see another grey hair or a new wrinkle. It’s called Gerascophobia, the fear of growing old aging. Growing old is more than the loss of youth. Growing old is also a fear of dying. Many conditions and attributes of aging are signs that are indicators of death and dying. Cancers, osteoporosis, Alzheimer’s disease, Parkinson’s disease, heart ailments, and organ failures make it difficult as one grows older to follow Dylan Thomas’ poetic advice to “rage against the dying of the light.” That’s why the studies of Jason Hope and Aubrey de Grey of the SENS Research Foundation are so vital.
Jason Hope is a Scottsdale, Arizona entrepreneur and philanthropist who has a passion for technology and its use to better serve the communities of the world. To that end he has positioned himself in the center of the anti-aging industry working tirelessly with Aubrey de Grey, founder and chief science officer of the SENS Research Foundation, in the battle against aging. The SENS Research Foundation is a research facility that uses regenerative medicines in the treatment of age related diseases. Every year the foundation hosts the Rejuvenation Biotechnology Conference hoping that the scientific, futuristic minds of those in attendance will create drugs that will effectively work against the aging process and the cellular and molecular damages it causes. Jason Hope helps push anti-aging efforts forward.
Nobody believes in this cause more than Jason Hope who recently made a $500,000 donation to the foundation. His generous largess along with others aided the foundation in the construction of a new laboratory and provided enough money to start a research program. Jason Hope applauds the SENS Research Foundation for their unique way of treating and combating aging. Mr. Hope believes that traditional medicine is limited in its effectiveness because it treats diseases after they happen while the foundation’s focus is on preventing the disease before they have a chance to attack the body.
The new laboratory has already experienced a phenomenal breakthrough in a program called “Age-breaker.” Age-breaker drugs are proficient in doing one thing: breaking down advanced glycation,the body’s natural metabolic waste, end products. Researchers now know that glucosepane is the body’s only AGEs, Advanced Glycation End products. This knowledge will advance ongoing and future research efforts, and it will encourage Jason Hope and other like-minded philanthropist to continue with their financial support.
About Jason Hope: twitter.com/jasonhope